Çiğdem Kahraman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Çiğdem Kahraman has a total of 56 co-authors. Here are the top co-authors by number of shared publications:
- İfFet İrEm Çankaya
Department of Pharmaceutical Botany, Faculty of Pharmacy, Hacettepe University, Ankara, Türkiye
7 shared publications - Suat Sari
Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Hacettepe University, Ankara 06230, Turkey
3 shared publications - Esra Küpeli Akkol
Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, Etiler, Ankara 06330, Türkiye
2 shared publications - Gülaçtı Topçu
Bezmialem Vakif University
2 shared publications - Melike Ekizoğlu
Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Hacettepe University, 06100 Ankara, Turkey
2 shared publications Zeliha S. Akdemir
Department of Pharmacognosy, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey
2 shared publications
Latest Publications
- 30 December 2025
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 46 (4) , 667-671
Evaluation of Acetylcholinesterase Inhibitory Activities of Selected Plants in the Light of Ethnobotanical and Phytochemical Perspectives
Alzheimer’s disease (AD) is the most common form of dementia, and treatment options only relieve the progression of the disease. Thus, the search for new therapeutic agents for AD remains an ongoing challenge. Utilizing the richness of chemical structures in natural sources is one of the most effective approaches in discovering new drug candidate molecules. For this purpose, this study aimed to evaluate the acetylcholinesterase enzyme inhibitory activities of Dysphania botrys (L.) Mosyakin & Clemants, Lotus corniculatus L. var. tenuifolius L., Noaea mucronata (Forssk.) Aschers. et Schweinf. ssp. mucronata, Vicia cracca L. ssp. stenophylla Vel. to assess their potential as natural sources. Ellman's colorimetric assay was used for the determination of enzyme inhibitory activity of n-hexane, dichloromethane, ethyl acetate, and n-butanol extracts of the plants, which were prepared by the partition of crude methanolic extracts by the corresponding solvents and the remaining aqueous phase.The dichloromethane extract of D. botrys between the 30-90 µg/ml concentrations exerted the highest inhibitory activity, with a maximum inhibitory value of 49.9%. Metabolites of active extracts that may be responsible for the activity deserve to be investigated, and further studies are needed.
- 30 December 2025
- Published by Cumhuriyet University in Cumhuriyet Science Journal
- Vol. 46 (4) , 667-671
Evaluation of Acetylcholinesterase Inhibitory Activities of Selected Plants in the Light of Ethnobotanical and Phytochemical Perspectives
Alzheimer’s disease (AD) is the most common form of dementia, and treatment options only relieve the progression of the disease. Thus, the search for new therapeutic agents for AD remains an ongoing challenge. Utilizing the richness of chemical structures in natural sources is one of the most effective approaches in discovering new drug candidate molecules. For this purpose, this study aimed to evaluate the acetylcholinesterase enzyme inhibitory activities of Dysphania botrys (L.) Mosyakin & Clemants, Lotus corniculatus L. var. tenuifolius L., Noaea mucronata (Forssk.) Aschers. et Schweinf. ssp. mucronata, Vicia cracca L. ssp. stenophylla Vel. to assess their potential as natural sources. Ellman's colorimetric assay was used for the determination of enzyme inhibitory activity of n-hexane, dichloromethane, ethyl acetate, and n-butanol extracts of the plants, which were prepared by the partition of crude methanolic extracts by the corresponding solvents and the remaining aqueous phase.The dichloromethane extract of D. botrys between the 30-90 µg/ml concentrations exerted the highest inhibitory activity, with a maximum inhibitory value of 49.9%. Metabolites of active extracts that may be responsible for the activity deserve to be investigated, and further studies are needed.
- Open Access
- 26 December 2025
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 64 (1) , 87-107
A scoping review of turmeric adulteration based on data from six continents
Turmeric (Curcuma longa) is widely used as a spice and in dietary/food supplements and herbal medicines. Reports assessing the authenticity of commercial products have shown that the ingredient is subject to adulteration with, among others, artificial dyes, undeclared diluents, and synthetic curcumin. This scoping review summarizes published data on adulteration of turmeric products sold as spice and dietary or food supplements to estimate the prevalence of non-authentic turmeric on the market. This scoping review was based on a literature analysis from Google Scholar, PubMed, ScienceDirect, Scopus, and Web of Science databases, covering publications from 2000 to 2025. Article selection was performed according to PRISMA-ScR guidelines. After the initial search, specific countries were added to refine the search. Of the 375 publications retrieved, 347 were eliminated as duplicates or because they lacked information on turmeric adulteration, adulteration of commercial products, or did not provide the number of adulterated samples. An additional 19 papers were found searching the citations, or by using Google Search with the keywords "Curcuma longa", "turmeric", "government report", and "adulteration". One more report from the CVUA Stuttgart was found using the keywords "Kurkuma", "Verfälschung", and "Report". In total, 48 papers were included in the review. A total of 48 publications representing 2235 commercial turmeric samples were included in the study. The overall adulteration rate was 20.0%, with spice samples having a slightly lower percentage of adulterated samples (20.4%) than dietary and food supplements (22.0%). Adulteration of turmeric remains a concern on markets worldwide.
- 26 December 2025
- Published by Taylor & Francis in Pharmaceutical Biology
- Vol. 64 (1) , 87-107
Open AccessA scoping review of turmeric adulteration based on data from six continents
Turmeric (Curcuma longa) is widely used as a spice and in dietary/food supplements and herbal medicines. Reports assessing the authenticity of commercial products have shown that the ingredient is subject to adulteration with, among others, artificial dyes, undeclared diluents, and synthetic curcumin. This scoping review summarizes published data on adulteration of turmeric products sold as spice and dietary or food supplements to estimate the prevalence of non-authentic turmeric on the market. This scoping review was based on a literature analysis from Google Scholar, PubMed, ScienceDirect, Scopus, and Web of Science databases, covering publications from 2000 to 2025. Article selection was performed according to PRISMA-ScR guidelines. After the initial search, specific countries were added to refine the search. Of the 375 publications retrieved, 347 were eliminated as duplicates or because they lacked information on turmeric adulteration, adulteration of commercial products, or did not provide the number of adulterated samples. An additional 19 papers were found searching the citations, or by using Google Search with the keywords "Curcuma longa", "turmeric", "government report", and "adulteration". One more report from the CVUA Stuttgart was found using the keywords "Kurkuma", "Verfälschung", and "Report". In total, 48 papers were included in the review. A total of 48 publications representing 2235 commercial turmeric samples were included in the study. The overall adulteration rate was 20.0%, with spice samples having a slightly lower percentage of adulterated samples (20.4%) than dietary and food supplements (22.0%). Adulteration of turmeric remains a concern on markets worldwide.
- 5 November 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (42)
Exploring the Bioactivity Potential of Prunus spinosa : Antioxidant, Antimicrobial, and In Silico Antidiabetic Insights
The fruits of Prunus spinosa L. have been consumed for dietary purposes and as a remedy for various conditions, including diabetes. This study aimed to isolate the secondary metabolites of P. spinosa fruits and evaluate their potential antidiabetic activities through in silico modelling. The antioxidant and antimicrobial properties of crude and sub‐extracts were evaluated as supportive of antidiabetic properties. The fruits were extracted with methanol and sequentially partitioned using chloroform, ethyl acetate, and n ‐butanol. The methanol extract was further subjected to chromatographic separation to obtain pure compounds; molecular docking was performed to predict their inhibitory potential against selected drug targets involved in diabetes pathophysiology. The extracts demonstrated moderate antioxidant and low antimicrobial activity, compared to the reference compounds. Since none of them was responsible for both activities, isolation studies were conducted on the crude methanol extract, from which benzylalcohol β ‐(6′′‐ β ‐xylopyranosyl)‐glucopyranoside and benzylalcohol β ‐(6′′‐ α ‐arabinopyranosyl)‐glucopyranoside were obtained. Both compounds were predicted to have the potential to inhibit α ‐glucosidase and sodium/glucose co‐transporter 2 (SGLT2). This study is the first record of two benzyl alcohol derivatives from P. spinosa . Molecular modelling studies indicate these derivatives may serve as key contributors to the plant's antidiabetic properties and provide a foundation for future experimental work.
- 5 November 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (42)
Exploring the Bioactivity Potential of Prunus spinosa : Antioxidant, Antimicrobial, and In Silico Antidiabetic Insights
The fruits of Prunus spinosa L. have been consumed for dietary purposes and as a remedy for various conditions, including diabetes. This study aimed to isolate the secondary metabolites of P. spinosa fruits and evaluate their potential antidiabetic activities through in silico modelling. The antioxidant and antimicrobial properties of crude and sub‐extracts were evaluated as supportive of antidiabetic properties. The fruits were extracted with methanol and sequentially partitioned using chloroform, ethyl acetate, and n ‐butanol. The methanol extract was further subjected to chromatographic separation to obtain pure compounds; molecular docking was performed to predict their inhibitory potential against selected drug targets involved in diabetes pathophysiology. The extracts demonstrated moderate antioxidant and low antimicrobial activity, compared to the reference compounds. Since none of them was responsible for both activities, isolation studies were conducted on the crude methanol extract, from which benzylalcohol β ‐(6′′‐ β ‐xylopyranosyl)‐glucopyranoside and benzylalcohol β ‐(6′′‐ α ‐arabinopyranosyl)‐glucopyranoside were obtained. Both compounds were predicted to have the potential to inhibit α ‐glucosidase and sodium/glucose co‐transporter 2 (SGLT2). This study is the first record of two benzyl alcohol derivatives from P. spinosa . Molecular modelling studies indicate these derivatives may serve as key contributors to the plant's antidiabetic properties and provide a foundation for future experimental work.
- 8 October 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 355 (Pt B) , 120692
Non-targeted metabolomic profiling of Cistus species and association with anticholinesterase efficacy for Alzheimer’s disease: In vitro and in silico evaluation
- 8 October 2025
- Published by Elsevier in Journal of Ethnopharmacology
- Vol. 355 (Pt B) , 120692
Non-targeted metabolomic profiling of Cistus species and association with anticholinesterase efficacy for Alzheimer’s disease: In vitro and in silico evaluation
- 3 October 2025
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 106 (4) , e70178
Unveiling a New Cholinesterase Inhibitor Iridoid From Verbascum uschakense (Murb.) Hub.‐Mor.: In Vitro and In Silico Evaluation
Verbascum L., a member of the Scrophulariaceae family, is the second‐largest genus in Turkish flora. It is represented by over 250 species, many of which have been used as folk medicine. This study aims to determine the cholinesterase inhibitory potential of secondary metabolites of Verbascum uschakense (Murb.) Hub.‐Mor, an endemic species to Türkiye that has not been studied phytochemically before. Gluroside, an iridoid glucoside, was isolated from V. uschakense through acetylcholinesterase (AChE) inhibitory activity‐guided fractionation alongside four other iridoid glucosides: ajugol, harpagide, aucubin, and catalpol. Additionally, three phenylethanoid glycosides—verbascoside, martinoside, and forsythoside B—were isolated from the antioxidant fractions evaluated using DPPH radical scavenging activity. Gluroside emerged as the most active compound against butyrylcholinesterase (BChE) with an IC 50 of 2.5 ± 0.02 μg/mL, exhibiting selectivity over AChE (37.69% inhibition at 200 μg/mL). Molecular modeling predicted strong electrostatic interactions between the glucosides and the catalytic residues of BChE. This is the first report of the isolation of gluroside from a Verbascum species and its cholinesterase inhibitory activity, underpinning the importance of V. uschakense and its secondary metabolites as a new class of cholinesterase inhibitors.
- 3 October 2025
- Published by Wiley in Chemical Biology & Drug Design
- Vol. 106 (4) , e70178
Unveiling a New Cholinesterase Inhibitor Iridoid From Verbascum uschakense (Murb.) Hub.‐Mor.: In Vitro and In Silico Evaluation
Verbascum L., a member of the Scrophulariaceae family, is the second‐largest genus in Turkish flora. It is represented by over 250 species, many of which have been used as folk medicine. This study aims to determine the cholinesterase inhibitory potential of secondary metabolites of Verbascum uschakense (Murb.) Hub.‐Mor, an endemic species to Türkiye that has not been studied phytochemically before. Gluroside, an iridoid glucoside, was isolated from V. uschakense through acetylcholinesterase (AChE) inhibitory activity‐guided fractionation alongside four other iridoid glucosides: ajugol, harpagide, aucubin, and catalpol. Additionally, three phenylethanoid glycosides—verbascoside, martinoside, and forsythoside B—were isolated from the antioxidant fractions evaluated using DPPH radical scavenging activity. Gluroside emerged as the most active compound against butyrylcholinesterase (BChE) with an IC 50 of 2.5 ± 0.02 μg/mL, exhibiting selectivity over AChE (37.69% inhibition at 200 μg/mL). Molecular modeling predicted strong electrostatic interactions between the glucosides and the catalytic residues of BChE. This is the first report of the isolation of gluroside from a Verbascum species and its cholinesterase inhibitory activity, underpinning the importance of V. uschakense and its secondary metabolites as a new class of cholinesterase inhibitors.
- Open Access
- 4 June 2025
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 29 (3) , 1187-1192
Antimicrobial activities of some Verbascum L. species against clinical isolates of Klebsiella pneumoniae causing lower respiratory tract infections
Increasing antibiotic resistance in Klebsiella pneumoniae has necessitated the development of novel antimicrobial therapies. In recent years, many studies have been conducted on using plants as antimicrobial agents, and many natural compounds have been found to be effective sources of antibacterial agents. In the present study, the antimicrobial activity of K. pneumoniae strains isolated from patients with lower respiratory tract infections (LRTIs) was investigated against some Verbascum L. species. Five K. pneumoniae strains, isolated from bronchoalveolar lavage (BAL) samples of patients with LRTIs, were identified by VITEK MS MALDI-TOF (BioMerieux, France). Then, the antimicrobial activity of 85% ethanol and 2% aqueous extracts of nine Verbascum species (V. ancyritanum Bornm., V. cheiranthifolium Boiss., V. georgicum Benth., V. kastamunicum Murb., V. lasianthum Boiss. ex Benth., V. mucronatum Lam., V. sinuatum L. subsp. sinuatum var. adenosepalum Murb., V. speciosum Schrad., V. uschakense Hub.-Mor.), three of which are endemic to Turkish flora, was investigated by using the microdilution method. Both 85% ethanol and 2% aqueous extracts of Verbascum species showed MIC values between 128 - 256 ƒÊg/mL and MBC in the range of 256 - 1024 ƒÊg/mL. The endemic species, V. ancyritanum presented the most effective antimicrobial activity. In the present study, the antimicrobial activity of endemic species, V. ancyritanum, V. kastamunicum, and V. uschakense, was investigated for the first time. All extracts were found to have moderate antimicrobial activity against the studied bacteria.
- 4 June 2025
- Published by Marmara University in Journal of Research in Pharmacy
- Vol. 29 (3) , 1187-1192
Open AccessAntimicrobial activities of some Verbascum L. species against clinical isolates of Klebsiella pneumoniae causing lower respiratory tract infections
Increasing antibiotic resistance in Klebsiella pneumoniae has necessitated the development of novel antimicrobial therapies. In recent years, many studies have been conducted on using plants as antimicrobial agents, and many natural compounds have been found to be effective sources of antibacterial agents. In the present study, the antimicrobial activity of K. pneumoniae strains isolated from patients with lower respiratory tract infections (LRTIs) was investigated against some Verbascum L. species. Five K. pneumoniae strains, isolated from bronchoalveolar lavage (BAL) samples of patients with LRTIs, were identified by VITEK MS MALDI-TOF (BioMerieux, France). Then, the antimicrobial activity of 85% ethanol and 2% aqueous extracts of nine Verbascum species (V. ancyritanum Bornm., V. cheiranthifolium Boiss., V. georgicum Benth., V. kastamunicum Murb., V. lasianthum Boiss. ex Benth., V. mucronatum Lam., V. sinuatum L. subsp. sinuatum var. adenosepalum Murb., V. speciosum Schrad., V. uschakense Hub.-Mor.), three of which are endemic to Turkish flora, was investigated by using the microdilution method. Both 85% ethanol and 2% aqueous extracts of Verbascum species showed MIC values between 128 - 256 ƒÊg/mL and MBC in the range of 256 - 1024 ƒÊg/mL. The endemic species, V. ancyritanum presented the most effective antimicrobial activity. In the present study, the antimicrobial activity of endemic species, V. ancyritanum, V. kastamunicum, and V. uschakense, was investigated for the first time. All extracts were found to have moderate antimicrobial activity against the studied bacteria.
- Open Access
- 22 June 2023
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 25, 1-32
Toxicology of pharmaceutical and nutritional longevity compounds
Aging is the most prominent risk factor for many diseases, which is considered to be a complicated biological process. The rate of aging depends on the effectiveness of important mechanisms such as the protection of DNA from free radicals, which protects the structural and functional integrity of cells and tissues. In any organism, not all organs may age at the same rate. Slowing down primary aging and reaching maximum lifespan is the most basic necessity. In this process, it may be possible to slow down or stabilise some diseases by using the compounds for both dietary and pharmacological purposes. Natural compounds with antioxidant and anti-inflammatory effects, mostly plant-based nutraceuticals, are preferred in the treatment of age-related chronic diseases and can also be used for other diseases. An increasing number of long-term studies on synthetic and natural compounds aim to elucidate preclinically and clinically the mechanisms underlying being healthy and prolongation of life. To delay age-related diseases and prolong the lifespan, it is necessary to take these compounds with diet or pharmaceuticals, along with detailed toxicological results. In this review, the most promising and utilised compounds will be highlighted and it will be discussed whether they have toxic effects in short/long-term use, although they are thought to be used safely.
- 22 June 2023
- Published by Cambridge University Press (CUP) in Expert Reviews in Molecular Medicine
- Vol. 25, 1-32
Open AccessToxicology of pharmaceutical and nutritional longevity compounds
Aging is the most prominent risk factor for many diseases, which is considered to be a complicated biological process. The rate of aging depends on the effectiveness of important mechanisms such as the protection of DNA from free radicals, which protects the structural and functional integrity of cells and tissues. In any organism, not all organs may age at the same rate. Slowing down primary aging and reaching maximum lifespan is the most basic necessity. In this process, it may be possible to slow down or stabilise some diseases by using the compounds for both dietary and pharmacological purposes. Natural compounds with antioxidant and anti-inflammatory effects, mostly plant-based nutraceuticals, are preferred in the treatment of age-related chronic diseases and can also be used for other diseases. An increasing number of long-term studies on synthetic and natural compounds aim to elucidate preclinically and clinically the mechanisms underlying being healthy and prolongation of life. To delay age-related diseases and prolong the lifespan, it is necessary to take these compounds with diet or pharmaceuticals, along with detailed toxicological results. In this review, the most promising and utilised compounds will be highlighted and it will be discussed whether they have toxic effects in short/long-term use, although they are thought to be used safely.
- 16 November 2022
- Published by Wiley in Chemistry & Biodiversity
- Vol. 19 (12) , e202200582
Bioactive Saponins of Primula vulgaris Huds. Promote Wound Healing through Inhibition of Collagenase and Elastase Enzymes: in Vivo, in Vitro and in Silico Evaluations
Primula vulgaris Huds. leaves and roots were used to treat skin damage and inflammation in Anatolian Folk Medicine. This study aimed to assess the ethnopharmacological use of the plant using in vivo, in vitro, and in silico test models. Linear incision and circular excision wound models were used to determine the in vivo wound‐healing potential of the plant extracts and fractions. In vitro assays including hyaluronidase, collagenase, and elastase inhibitory activities were carried out for the active compounds to discover their activity pathways. Structure‐based molecular modeling was performed to understand inhibitory mechanisms regarding collagenase and elastase at the molecular level. The butanol fraction of the roots of P. vulgaris showed the highest wound‐healing activity. Through activity‐guided fractionation and isolation techniques, primulasaponin I (1) and primulasaponin I methyl ester (2) were stated as the major active compounds. These compounds exerted their activities through the inhibition of collagenase and elastase enzymes. Primulasaponin I methyl ester isolated from butanol fraction was found to be the strongest agent, especially with the values of 29.65 % on collagenase and 38.92 % on elastase inhibitory activity assays, as well as molecular docking studies. The present study supports scientific data for the traditional use of P. vulgaris and the wound healing properties of the plant can be referred to secondary metabolites as especially saponins found in the roots.
- 16 November 2022
- Published by Wiley in Chemistry & Biodiversity
- Vol. 19 (12) , e202200582
Bioactive Saponins of Primula vulgaris Huds. Promote Wound Healing through Inhibition of Collagenase and Elastase Enzymes: in Vivo, in Vitro and in Silico Evaluations
Primula vulgaris Huds. leaves and roots were used to treat skin damage and inflammation in Anatolian Folk Medicine. This study aimed to assess the ethnopharmacological use of the plant using in vivo, in vitro, and in silico test models. Linear incision and circular excision wound models were used to determine the in vivo wound‐healing potential of the plant extracts and fractions. In vitro assays including hyaluronidase, collagenase, and elastase inhibitory activities were carried out for the active compounds to discover their activity pathways. Structure‐based molecular modeling was performed to understand inhibitory mechanisms regarding collagenase and elastase at the molecular level. The butanol fraction of the roots of P. vulgaris showed the highest wound‐healing activity. Through activity‐guided fractionation and isolation techniques, primulasaponin I (1) and primulasaponin I methyl ester (2) were stated as the major active compounds. These compounds exerted their activities through the inhibition of collagenase and elastase enzymes. Primulasaponin I methyl ester isolated from butanol fraction was found to be the strongest agent, especially with the values of 29.65 % on collagenase and 38.92 % on elastase inhibitory activity assays, as well as molecular docking studies. The present study supports scientific data for the traditional use of P. vulgaris and the wound healing properties of the plant can be referred to secondary metabolites as especially saponins found in the roots.
- 23 June 2022
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 32 (4) , 537-543
Anti-inflammatory and Antinociceptive Potential of Verbascum latisepalum
- 23 June 2022
- Published by Springer Nature in Revista Brasileira de Farmacognosia
- Vol. 32 (4) , 537-543
Anti-inflammatory and Antinociceptive Potential of Verbascum latisepalum